Apimeds Pharmaceuticals US (APUS) Total Assets (2022 - 2026)
Apimeds Pharmaceuticals US (APUS) total assets from Dec 31, 2022 to Mar 31, 2026. The current Apimeds Pharmaceuticals US (APUS) total assets is $141M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Total Assets
Total Assets
Apimeds Pharmaceuticals US (APUS) Total Assets CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +120344.44% |
Annual Total Assets change of Apimeds Pharmaceuticals US (APUS)
| Year | Total Assets | Change |
|---|---|---|
| 2024 | $10K | -97.62% |
| 2023 | $420K | N/A |
| 2022 | $0 | N/A |
Comparison Apimeds Pharmaceuticals US (APUS) total assets with competitors
Apimeds Pharmaceuticals US (APUS) total assets is $141.22M.